ResearcherFirst Affiliated Hospital of Dalian Medical UniversityActive in the last 2 years

Jifeng Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9603-013X, 0000-0003-4996-038X; OpenAlex author ID A5100631841. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper

Papers 1

Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics. Co-author DOI 10.1038/s41598-024-68385-9 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qihang Yuan · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗
Bing Qi · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗
Xu Chen · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗
Dong Shang · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗
Shuang Li · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.